Chugai Launches New Mid-term Plan With Investment Prospects; Eisai Battles For Its Growth Drivers – Japan Earnings Profiles
This article was originally published in PharmAsia News
Executive Summary
Japan’s earnings season highlights new global strategies for Japan’s leading pharmaceutical companies.